[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2024 U.S. Transfusion Diagnostics Market: Immunohematology and NAT Testing-Supplier Shares and Strategies, Innovative technologies, Instrumentation Review, Emerging Opportunities

July 2020 | 460 pages | ID: UF4B5892AEDFEN
Venture Planning Group

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
LeadingMarketResearch.com's new report is a strategic analysis prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies.

The report is available by section, and can be customized to specific information needs and budget.

Rationale

During the next five years, the US blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology.

The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.

Strategic Recommendations
  • New product development opportunities with significant market appeal.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
The report explores future marketing and technological trends in the US; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.

Sales and Market Share Analysis

Sales and market share estimates of leading suppliers of blood banking of reagents and instruments, by individual product.

Competitive Assessments

Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D.

Market Segmentation Analysis
  • Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers.
  • Test volume and sales forecasts for over 40 blood banking tests, including NAT, by market segment:
    • Blood Centers
    • Plasma Fractionation Facilities
    • Hospitals
    • Commercial/Private Laboratories
    • Military Blood Banks
Current and Emerging Products
  • Analysis of current and emerging blood banking tests.
  • Review of automated and semi-automated analyzers, including their operating characteristics, features, and selling prices.
Technology Review
  • Assessment of current and emerging technologies, and their potential applications for the blood banking market.
  • Comprehensive lists of companies developing or marketing new technologies and products by test.
Contains 460 pages and 53 tables
I. INTRODUCTION

II. WORLDWIDE MARKET OVERVIEW

1. Business Environment
2. Market Structure
3. Market Size and Growth

III. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary

IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts

V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection

VI. WORLDWIDE TECHNOLOGY AND MARKET OVERVIEW

A. Major Blood Typing, Grouping and Infectious Disease Screening Tests
  1. Blood Typing and Grouping Tests
    a. ABO
    b. Antibody Panels
    c. Antibody Screening
    d. Antigen Typing
    e. Antiglobulin Test
    f. Crossmatch
    g. HLA Typing
    h. Rh
    i. Other Blood Groups
  2. Infectious Disease Screening Tests
    a. AIDS/HIV
    Background
      Diagnostic Tests
        Enzyme Immunoassay
        Viral Load/Drug Resistance Testing
        Genotype and Phenotype Testing
      Blood Banking Considerations
    b. Hepatitis Markers
      Hepatitis A
      Hepatitis B
      Hepatitis C
      Hepatitis D (Delta Hepatitis)
      Hepatitis E
      Hepatitis G
      Vaccines and Drugs
    c. Cytomegalovirus
    Background
      Diagnostic Tests
      Vaccines and Drugs
    d. Syphilis
    Background
      Diagnostic Tests
      Vaccines and Drugs
    e. West Nile Virus
    Background
      Clinical Syndromes
      Diagnostic Tests
      Vaccines and Drugs
    f. Parvovirus B19
      Microbiology
      Epidemiology
      Clinical Syndromes
      Diagnostic Test
      Vaccines and Drugs
    g. Creutzfeldt-Jakob’s Disease
    Background
      Transmission
      Diagnostic Tests
      Vaccines and Drugs
    h. Malaria
    i. Chagas Disease
    j. Babesiosis
  3. Pathogen Reduction
  4. Leukocyte Reduction
    Background
    Methods
B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Blood Typing, Grouping and Infectious Disease Screening Automated and Semiautomated Analyzers
C. Major Blood Banking Technologies and Their Potential Applications
  1. Molecular Diagnostics
  2. Monoclonal and Polyclonal Antibodies
  3. Immunoassays
  4. Microtitration Plates
  5. IT and Automation
  6. Lasers
  7. Robotics
  8. Synthetic Red Cell Substitutes
  9. Genetically Engineered Blood Components
  10. Blood Preservation
  11. Autologous Blood Transfusion/Freezing

VII. COUNTRY BLOOD BANKING MARKET

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, by Market Segment, Major Supplier Sales and Market Shares

VIII. COMPETITIVE ASSESSMENTS

Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Diagast
DiaSorin
Fujirebio
Grifols
Hologic
Immucor
LabCorp
Ortho-Clinical Diagnostics
Proteome Sciences
Quest Diagnostics
Quidel
Roche
Siemens Healthineers
Tecan
Thermo Fisher

LIST OF TABLES

Major Companies Developing or Marketing Blood Typing and Grouping Tests
Major Companies Developing or Marketing HLA Typing Tests
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Blood Bank Analyzers
Executive Summary Table: U.S.A., Total Blood Bank Test Volume and Reagent Sales Forecast by Test Category
U.S.A., Estimated Number of Inpatient and Ambulatory Surgeries
U.S.A., Facilities Performing Blood Bank Tests by Market Segment
U.S.A., Hospital Laboratories Performing Blood Bank Tests by Bed Size
U.S.A., Commercial/Private Laboratories Performing Blood Bank Tests by Annual Test Volume Forecast
U.S.A., Facilities Collecting Whole Blood And Plasma by Market Forecast Segment
U.S.A., Whole Blood and Plasma Collections By Market Forecast Segment
U.S.A., All Market Segments Blood Typing and Grouping Test Volume by Market Forecast Segment
U.S.A., All Market Segments Blood Typing And Grouping Test Volume Forecast
U.S.A., Hospital Laboratories Blood Typing and Grouping Test Volume Forecast
U.S.A., Community and Regional Blood Centers Blood Typing and Grouping Test Volume Forecast
U.S.A., Commercial/Private Laboratories Blood Typing and Grouping Test Volume Forecast
U.S.A., Plasma Fractionation Centers Blood Typing and Grouping Test Volume Forecast
U.S.A., Military Blood Banks Blood Typing and Grouping Test Volume Forecast
U.S.A., All Market Segments Infectious Disease Screening Test Volume Forecast By Market Segment
U.S.A., All Market Segments Infectious Disease Screening Test Volume Forecast
U.S.A., Community and Regional Centers Infectious Disease Screening Test Volume Forecast
U.S.A., Plasma Fractionation Centers Infectious Disease Screening Test Volume Forecast
U.S.A., Hospital Blood Banks Infectious Disease Screening Test Volume Forecast
U.S.A., Military Blood Banks Infectious Disease Screening Test Volume Forecast
U.S.A., All Market Segments Blood Typing And Grouping Reagent Market Forecast by Market Segment
U.S.A., All Market Segments Blood Typing And Grouping Reagent Market Forecast by Market Segment
U.S.A., Hospital Blood Banks Blood Typing And Grouping Reagent Market Forecast by Major Test
U.S.A., Community and Regional Blood Centers Blood Typing and Grouping Reagent Market Forecast By Major Test
U.S.A., Commercial/Private Laboratories Blood Typing and Grouping Reagent Market Forecast By Major Test
U.S.A., Plasma Fractionation Centers Blood Typing and Grouping Reagent Market Forecast By Major Test
U.S.A., Military Blood Banks Blood Typing And Grouping Reagent Market Forecast by Major Test
U.S.A., All Market Segments Infectious Disease Screening Reagent Market by Market Forecast Segment
U.S.A., All Market Segments Infectious Disease Screening Reagent Market by Market Forecast Segment
U.S.A., Community and Regional Centers Infectious Disease Screening Reagent Market Forecast By Test
U.S.A., Plasma Fractionation Centers Infectious Disease Screening Reagent Market Forecast By Test
U.S.A., Hospital Blood Banks Infectious Disease Screening Reagent Market Forecast By Test
U.S.A., Military Blood Banks Infectious Disease Screening Reagent Market Forecast By Test
U.S.A., Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares
U.S.A., HIV/HTLV Blood Screening Market, Reagent Sales by Major Supplier
U.S.A., Hepatitis Blood Screening Market, Reagents Sales by Major Supplier
U.S.A., Hepatitis C Blood Screening Market, Reagent Sales By Major Supplier
U.S.A., HIV/Hepatitis C NAT Market, Reagent Sales By Major Supplier
U.S.A., West Nile Virus NAT Market, Reagent Sales by Major Supplier
U.S.A., CMV Blood Screening Market, Reagent Sales by Major Supplier
U.S.A., Syphilis Blood Screening Market, Reagent Sales by Major Supplier


More Publications